Acupuncture Effect on the Rate of Maturation in Post Term Pregnancies.
MATUPUNCTURE
1 other identifier
interventional
128
1 country
1
Brief Summary
Brief Summary Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis. (Limit: 5000 characters) Example: The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED). The first purpose of this randomized study is to determine if five points of acupuncture : 4GI, 6RP, 34VB, 36E, 3F could improve the bishop score for prolonged pregnancies and decrease the rate of maturation. The protocol of our study consists of proposing to the pregnant women one or two acupuncture sessions the term's day and three days later. Once the consent is signed, women are randomly included in the experimental or placebo arm. In the experimental arm, midwives puncture five points : 4GI, 6 RP, 34VB, 36E, 3F on each side while in the placebo arm, they puncture just one point : 16 HM on each side. The maturation's rate between the two groups will be compared by a Fisher's exact test and analyzed in function parity (nulliparous or multiparous) and number of sessions (one or two) with a model of univariate and multivariate logistic regression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2021
CompletedStudy Start
First participant enrolled
March 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2021
CompletedSeptember 22, 2021
September 1, 2021
6 months
January 22, 2021
September 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Bishop score
cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required (The highest possible score is 13 and the lowest possible score is 0)
At 41 weeks of amenorrhea
Bishop score
cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required
3 days after the term of pregnancy
Bishop score
cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required
5 days after the term of pregnancy
Secondary Outcomes (4)
Rate spontaneous labour
At 41 weeks 5 days of amenorrhea
Duration labor
At 41 weeks 5 days of amenorrhea
Rate of delivery with medical intervention
At 41 weeks 5 days of amenorrhea
Rate of delivery by cesarean
At 41 weeks 5 days of amenorrhea
Study Arms (2)
Acupuncture
EXPERIMENTALIn the experimental arm, pregnant women at term will benefit one or two acupuncture sessions with five points : 4GI, 6RP, 34VB,36E,3F. The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.
Placebo acupuncture
PLACEBO COMPARATORIn the placebo arm, pregnant women will benefit one or two acupuncture sessions with one point which is located outside the acupuncture meridian. The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.
Interventions
Eligibility Criteria
You may qualify if:
- Nulliparous or multipares with physiological pregnancy at 41 weeks
- Cephalic foetal presentation,
- Healthy or unicicatricial uterus,
- Major patientes,
- Speaking french,
- Term of the pregnancy determinated with a dating ultrasound between 11 weeks and 13 weeks+ 6 days,
- Having signed the form of consent participation.
You may not qualify if:
- Foetal or maternal diseases requiring a maturation before 41 weeks : pre eclampsia, pre-existing diabetes, imbalance gestational diabetes, threat premature delivery treat with tocolytic, macrosomia or intrauterine growth retardation,
- Diseases discoveries at 41 weeks : pre eclampsia, moves of the baby decrease, low amniotic fluid,anomalies of the foetal heartbeat
- Circled pregnancy,
- Twins or more,
- Foetal death in utero, medical termination of pregnancy,
- Unstuck membranes,
- Minor patients
- Patients who benefited acupuncture during pregnancy ,
- Imprecise term of delivery,
- Podalic presentation
- Patients under supervision or curatorship,
- Patients without social security.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, 91106, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Women will be distributed randomly in the experimental or the placebo arm. They won't know that the point 16 HM isn't effective on cervix maturation. They will believe that both techniques work.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2021
First Posted
February 8, 2021
Study Start
March 9, 2021
Primary Completion
September 16, 2021
Study Completion
September 16, 2021
Last Updated
September 22, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share